Position in CVM
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$42
-$82 QoQ
Shares Held
41
+5.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 41 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 7%
Shared 0%
None 93%
Common Shares in CVM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,716,934,888 across 523 Biotechnology names. CVM ranks #498 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in CVM
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $42 | 41 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $124 | 39 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $310 | 59 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $4,350 | 473 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $1,114 | 487 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $3,296 | 14,336 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $8,260 | 20,654 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $15,195 | 14,336 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $27,399 | 23,621 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $34,606 | 18,119 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $118,041 | 43,398 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $24,117 | 19,295 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $52,556 | 21,808 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $58,753 | 25,325 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $75,213 | 32,007 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $122,309 | 39,583 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $672,117 | 149,361 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $386,891 | 98,446 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $580,116 | 81,707 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $797,333 | 72,551 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $660,476 | 76,092 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $737,076 | 48,460 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $835,077 | 71,619 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $747,174 | 58,602 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $894,886 | 59,979 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $495,642 | 42,950 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||